Cardiac Mapping Market by Type (Contact Cardiac Mapping System, Non-Contact Cardiac Mapping System), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia), Technology, End-User - Global Forecast 2024-2030

Cardiac Mapping Market by Type (Contact Cardiac Mapping System, Non-Contact Cardiac Mapping System), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia), Technology, End-User - Global Forecast 2024-2030


The Cardiac Mapping Market size was estimated at USD 2.11 billion in 2023 and expected to reach USD 2.33 billion in 2024, at a CAGR 10.55% to reach USD 4.26 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Mapping Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Mapping Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Mapping Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acutus Medical, AngioDynamics, Inc., APN Health, LLC, APT Medical Inc., Biosense Webster, Inc., Biosig Technologies, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, Catheter Precision, Inc. by Ra Medical Systems, Inc., CoreMap Inc., EP Solutions SA, EPMap-System GmbH, Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic, Inc., Microport Scientific Corporation, and Siemens AG.

Market Segmentation & Coverage


This research report categorizes the Cardiac Mapping Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Contact Cardiac Mapping System
Basket Catheter Mapping System

Electroanatomical Mapping System

Traditional Endocardial Catheter Mapping System
Non-Contact Cardiac Mapping System
Indication
Atrial Fibrillation
Atrial Flutter
Atrioventricular Nodal Reentry Tachycardia
Technology
Cardiac Radionuclide Imaging
Magnetic Navigation System
Remote Navigation System
Robotic Navigation System
End-User
Ambulatory Surgical Center
Diagnosis Center
Hospital & Clinic
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiac Mapping Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Mapping Market?
3. What are the technology trends and regulatory frameworks in the Cardiac Mapping Market?
4. What is the market share of the leading vendors in the Cardiac Mapping Market?
5. Which modes and strategic moves are suitable for entering the Cardiac Mapping Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Mapping Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing burden of cardiovascular diseases worldwide
5.1.1.2. Increasing consumer awareness towards early diagnosis and treatment of cardiac diseases
5.1.1.3. Growing adoption of 3D cardiac mapping
5.1.2. Restraints
5.1.2.1. High costs associated with cardiac mapping procedures and products
5.1.3. Opportunities
5.1.3.1. Advancements in cardiac mapping technologies
5.1.3.2. Rising approvals for novel cardiac mapping solutions
5.1.4. Challenges
5.1.4.1. Limitations and lack of awareness of cardiac mapping solutions
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cardiac Mapping Market, by Type
6.1. Introduction
6.2. Contact Cardiac Mapping System
6.3.1. Basket Catheter Mapping System
6.3.2. Electroanatomical Mapping System
6.3.3. Traditional Endocardial Catheter Mapping System
6.3. Non-Contact Cardiac Mapping System
7. Cardiac Mapping Market, by Indication
7.1. Introduction
7.2. Atrial Fibrillation
7.3. Atrial Flutter
7.4. Atrioventricular Nodal Reentry Tachycardia
8. Cardiac Mapping Market, by Technology
8.1. Introduction
8.2. Cardiac Radionuclide Imaging
8.3. Magnetic Navigation System
8.4. Remote Navigation System
8.5. Robotic Navigation System
9. Cardiac Mapping Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Diagnosis Center
9.4. Hospital & Clinic
10. Americas Cardiac Mapping Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cardiac Mapping Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cardiac Mapping Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Acutus Medical
14.1.3. AngioDynamics, Inc.
14.1.4. APN Health, LLC
14.1.5. APT Medical Inc.
14.1.6. Biosense Webster, Inc.
14.1.7. Biosig Technologies, Inc.
14.1.8. BIOTRONIK SE & Co KG
14.1.9. Boston Scientific Corporation
14.1.10. Catheter Precision, Inc. by Ra Medical Systems, Inc.
14.1.11. CoreMap Inc.
14.1.12. EP Solutions SA
14.1.13. EPMap-System GmbH
14.1.14. Johnson & Johnson Services, Inc.
14.1.15. Kardium Inc.
14.1.16. Koninklijke Philips N.V.
14.1.17. Lepu Medical Technology(Beijing)Co.,Ltd.
14.1.18. Medtronic, Inc.
14.1.19. Microport Scientific Corporation
14.1.20. Siemens AG
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. CARDIAC MAPPING MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC MAPPING MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC MAPPING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC MAPPING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC MAPPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC MAPPING MARKET DYNAMICS
FIGURE 7. CARDIAC MAPPING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. CARDIAC MAPPING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC MAPPING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. CARDIAC MAPPING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CARDIAC MAPPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. CARDIAC MAPPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CARDIAC MAPPING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. CARDIAC MAPPING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC MAPPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC MAPPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC MAPPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC MAPPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIAC MAPPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIAC MAPPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MAPPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC MAPPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC MAPPING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CARDIAC MAPPING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings